December 10 2007
GlaxoSmithKline And OncoMed Pharmaceuticals Form Strategic Alliance To Develop Cancer Stem Cell Antibody Therapeutics

October 30 2007
OncoMed Pharmaceuticals Appoints William D. Waddill, Senior Vice President and Chief Financial Officer

February 21 2007
OncoMed Pharmaceuticals Appoints Steven E. Benner, M.D., Senior Vice President and Chief Medical Officer

January 17 2007
The New England Journal of Medicine Publishes Study Identifying A Tumorigenic Cancer Cell Gene Signature That Appears Predictive Of Clinical Outcomes

October 17 2006
OncoMed Pharmaceuticals, Inc. Granted Fundamental Patent For Identifying Therapeutics Targeting Cancer Stem Cells

January 10 2006
OncoMed Pharmaceuticals, Inc. Granted Fundamental Patent For Isolation And Use Of Solid Tumor Stem Cells

December 01 2005
OncoMed Pharmaceuticals Appoints Paul J. Hastings President And Chief Executive Officer